Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Alfredo Sánchez-Hernández"'
Autor:
Roberto Serna-Blasco, Estela Sánchez-Herrero, Lucía Robado de Lope, Sandra Sanz-Moreno, Alejandro Rodríguez-Festa, Dunixe Ares-Trotta, Alberto Cruz-Bermúdez, Fabio Franco, Alfredo Sánchez-Hernández, María de Julián Campayo, Carlos García-Girón, Manuel Dómine, Ana Blasco, José M. Sánchez, Juana Oramas, Joaquim Bosch-Barrera, María Á. Sala, María Sereno, Atocha Romero, Mariano Provencio
Publikováno v:
Cancers, Vol 14, Iss 18, p 4446 (2022)
Tumor molecular profiling upon disease progression enables investigations of the tumor evolution. Next-generation sequencing (NGS) of liquid biopsies constitutes a noninvasive readily available source of tumor molecular information. In this study, 12
Externí odkaz:
https://doaj.org/article/fbefb4723b93488996868c6f1d0d8a8d
Autor:
María Guirado, Elena Fernández Martín, Alberto Fernández Villar, Arturo Navarro Martín, Alfredo Sánchez-Hernández
Publikováno v:
Clinical and Translational Oncology. 24:1549-1568
Introduction Due to the importance of lung cancer early treatment because of its severity and extent worldwide a systematic literature review was conducted about the impact of delays in waiting times on the disease prognosis. Materials and Methods We
Autor:
Mariano Provencio, Ana Laura Ortega, Juan Coves-Sarto, Virginia Calvo, Raquel Marsé-Fabregat, Manuel Dómine, María Guirado, Enric Carcereny, Natalia Fernández, Ruth Álvarez, Remei Blanco, Luis León-Mateos, José Miguel Sánchez-Torres, Ivana Gabriela Sullivan, Manuel Cobo, Alfredo Sánchez-Hernández, Bartomeu Massuti, Belen Sierra-Rodero, Cristina Mártinez-Toledo, Roberto Serna-Blasco, Atocha Romero, Alberto Cruz-Bermúdez
Publikováno v:
JAMA oncology.
ImportanceAntiangiogenic drug combinations with anti–programmed cell death 1 protein and anti–programmed cell death 1 ligand 1 (PD-L1) agents are a novel treatment option for lung cancer. However, survival remains limited, and the activity of the
Autor:
Roberto, Serna-Blasco, Estela, Sánchez-Herrero, Lucía, Robado de Lope, Sandra, Sanz-Moreno, Alejandro, Rodríguez-Festa, Dunixe, Ares-Trotta, Alberto, Cruz-Bermúdez, Fabio, Franco, Alfredo, Sánchez-Hernández, María de Julián, Campayo, Carlos, García-Girón, Manuel, Dómine, Ana, Blasco, José M, Sánchez, Juana, Oramas, Joaquim, Bosch-Barrera, María Á, Sala, María, Sereno, Atocha, Romero, Mariano, Provencio
Publikováno v:
Cancers. 14(18)
Tumor molecular profiling upon disease progression enables investigations of the tumor evolution. Next-generation sequencing (NGS) of liquid biopsies constitutes a noninvasive readily available source of tumor molecular information. In this study, 12
Autor:
Berta Hernandez, J. Coves, María Ángeles Sala, Ana Blasco, Ana Royuela, Joaquim Bosch-Barrera, A. Padilla, Roberto Serna-Blasco, María Sereno, Juana Oramas, María de Julián Campayo, Coralia Bueno, V. Calvo, Atocha Romero, José Balsalobre, F. Franco, Ana Laura Ortega, Milda Auglytė, Jose Miguel Sanchez, Mariano Provencio, Eloisa Jantus-Lewintre, X. Mielgo, Remedios Blanco, Carlos García-Girón, L.E. Chara, Miguel Angel Molina-Vila, Manuel Domine, Alfredo Sánchez-Hernández
Publikováno v:
European Journal of Cancer. 149:61-72
Survival data support the use of first-line osimertinib as the standard of care for epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC). However, it remains unclear whether upfront osimertinib is superior to sequential
Autor:
Cristina Candal-Pedreira, Alberto Ruano-Ravina, Virginia Calvo de Juan, Manuel Cobo, José Manuel Trigo, Enric Carcereny, Marc Cucurull, Rafael López Castro, Eduardo Solís García, Amparo Sánchez-Gastaldo, Bartomeu Massutí, Delvys Rodríguez-Abreu, Anna Estival, María Guirado Risueño, María Pamiés Ramón, Rosario García Campelo, Guillermo Alonso-Jáudenes, Carlos Camps, Edel del Barco Morillo, Clara González Ojea, Manuel Dómine, Alfredo Sanchez-Hernandez, Joaquím Bosch-Barrera, María Ángeles Sala González, Mariano Provencio
Publikováno v:
ERJ Open Research, Vol 9, Iss 6 (2023)
Objectives The aim of the study was to ascertain the percentage of Spanish lung cancer cases that would fulfil the lung cancer screening inclusion criteria recommended by the United States Preventive Service Task Force (USPSTF) in 2013 and 2021. Meth
Externí odkaz:
https://doaj.org/article/a612acb88ba047f79e4cc339b0b86a9c
Publikováno v:
ComHumanitas, Vol 6, Iss 1, Pp 112-132 (2015)
A partir del modelo de análisis ADN de las series televisivas, los autores abordan la serie Six Feet Under, su estructura narrativa, su lenguaje audiovisual, así como la construcción psicológica y moral de los personajes que en ella convergen par
Autor:
Jesús García-Donas, Luis León-Mateos, Aranzazu Gonzalez del Alba, Begoña Mellado, Jose Angel Arranz, Josep Mª Piulats, Begoña Perez-Valderrama, Alfredo Sánchez-Hernández, Miguel Angel Climent, Javier Cassinello, Mª José Méndez-Vidal
Publikováno v:
Critical Reviews in Oncology/Hematology. 96:308-318
Prostate cancer is the most prevalent male urogenital malignancy. Approximately 30% of patients with prostate cancer will develop advanced disease. Androgen deprivation therapy achieves disease control in about 90% of these patients, but the majority
Autor:
Ana Delgado-Prada, Julián Borrás, Roxana Farzanegan, María Cruz Torres Gorriz, Adrián Germán-Sánchez, Raquel Cervera Aznar, Isabela Raducan, Jose Vicente Castelló, Alfredo Sanchez-Hernandez, Ernesto Enrique
Publikováno v:
Clinical and Molecular Allergy, Vol 20, Iss 1, Pp 1-4 (2022)
Abstract Background Ifosfamide is an alkylating agent used in the treatment of a wide range of tumours. Because of known side effects it is usually administered in combination with mesna, a thiol agent with uroprotective activity, to reduce them and
Externí odkaz:
https://doaj.org/article/f089568cbcee4426b45074593ab110cf
Autor:
Joaquin Casal Rubio, Oscar Juan, Alfredo Sánchez Hernández, Sergio Vázquez, V. Giner, Martin Lázaro Quintela, Francisco Aparisi, José Luis Fírvida, José Manuel Pérez Muñoz, Jose Garcia Sanchez, Regina Gironés
Publikováno v:
Journal of Thoracic Oncology. 12:S853